Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs

Abstract The dynamic contrast-enhanced MR imaging plays a crucial role in evaluating the effectiveness of neoadjuvant chemotherapy (NAC) even since its early stage through the prediction of the final pathological complete response (pCR). In this study, we proposed a transfer learning approach to pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Colomba Comes, Annarita Fanizzi, Samantha Bove, Vittorio Didonna, Sergio Diotaiuti, Daniele La Forgia, Agnese Latorre, Eugenio Martinelli, Arianna Mencattini, Annalisa Nardone, Angelo Virgilio Paradiso, Cosmo Maurizio Ressa, Pasquale Tamborra, Vito Lorusso, Raffaella Massafra
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0c54abc80b30475eb5c5e7ab5ee519b9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c54abc80b30475eb5c5e7ab5ee519b9
record_format dspace
spelling oai:doaj.org-article:0c54abc80b30475eb5c5e7ab5ee519b92021-12-02T16:24:49ZEarly prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs10.1038/s41598-021-93592-z2045-2322https://doaj.org/article/0c54abc80b30475eb5c5e7ab5ee519b92021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93592-zhttps://doaj.org/toc/2045-2322Abstract The dynamic contrast-enhanced MR imaging plays a crucial role in evaluating the effectiveness of neoadjuvant chemotherapy (NAC) even since its early stage through the prediction of the final pathological complete response (pCR). In this study, we proposed a transfer learning approach to predict if a patient achieved pCR (pCR) or did not (non-pCR) by exploiting, separately or in combination, pre-treatment and early-treatment exams from I-SPY1 TRIAL public database. First, low-level features, i.e., related to local structure of the image, were automatically extracted by a pre-trained convolutional neural network (CNN) overcoming manual feature extraction. Next, an optimal set of most stable features was detected and then used to design an SVM classifier. A first subset of patients, called fine-tuning dataset (30 pCR; 78 non-pCR), was used to perform the optimal choice of features. A second subset not involved in the feature selection process was employed as an independent test (7 pCR; 19 non-pCR) to validate the model. By combining the optimal features extracted from both pre-treatment and early-treatment exams with some clinical features, i.e., ER, PgR, HER2 and molecular subtype, an accuracy of 91.4% and 92.3%, and an AUC value of 0.93 and 0.90, were returned on the fine-tuning dataset and the independent test, respectively. Overall, the low-level CNN features have an important role in the early evaluation of the NAC efficacy by predicting pCR. The proposed model represents a first effort towards the development of a clinical support tool for an early prediction of pCR to NAC.Maria Colomba ComesAnnarita FanizziSamantha BoveVittorio DidonnaSergio DiotaiutiDaniele La ForgiaAgnese LatorreEugenio MartinelliArianna MencattiniAnnalisa NardoneAngelo Virgilio ParadisoCosmo Maurizio RessaPasquale TamborraVito LorussoRaffaella MassafraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maria Colomba Comes
Annarita Fanizzi
Samantha Bove
Vittorio Didonna
Sergio Diotaiuti
Daniele La Forgia
Agnese Latorre
Eugenio Martinelli
Arianna Mencattini
Annalisa Nardone
Angelo Virgilio Paradiso
Cosmo Maurizio Ressa
Pasquale Tamborra
Vito Lorusso
Raffaella Massafra
Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
description Abstract The dynamic contrast-enhanced MR imaging plays a crucial role in evaluating the effectiveness of neoadjuvant chemotherapy (NAC) even since its early stage through the prediction of the final pathological complete response (pCR). In this study, we proposed a transfer learning approach to predict if a patient achieved pCR (pCR) or did not (non-pCR) by exploiting, separately or in combination, pre-treatment and early-treatment exams from I-SPY1 TRIAL public database. First, low-level features, i.e., related to local structure of the image, were automatically extracted by a pre-trained convolutional neural network (CNN) overcoming manual feature extraction. Next, an optimal set of most stable features was detected and then used to design an SVM classifier. A first subset of patients, called fine-tuning dataset (30 pCR; 78 non-pCR), was used to perform the optimal choice of features. A second subset not involved in the feature selection process was employed as an independent test (7 pCR; 19 non-pCR) to validate the model. By combining the optimal features extracted from both pre-treatment and early-treatment exams with some clinical features, i.e., ER, PgR, HER2 and molecular subtype, an accuracy of 91.4% and 92.3%, and an AUC value of 0.93 and 0.90, were returned on the fine-tuning dataset and the independent test, respectively. Overall, the low-level CNN features have an important role in the early evaluation of the NAC efficacy by predicting pCR. The proposed model represents a first effort towards the development of a clinical support tool for an early prediction of pCR to NAC.
format article
author Maria Colomba Comes
Annarita Fanizzi
Samantha Bove
Vittorio Didonna
Sergio Diotaiuti
Daniele La Forgia
Agnese Latorre
Eugenio Martinelli
Arianna Mencattini
Annalisa Nardone
Angelo Virgilio Paradiso
Cosmo Maurizio Ressa
Pasquale Tamborra
Vito Lorusso
Raffaella Massafra
author_facet Maria Colomba Comes
Annarita Fanizzi
Samantha Bove
Vittorio Didonna
Sergio Diotaiuti
Daniele La Forgia
Agnese Latorre
Eugenio Martinelli
Arianna Mencattini
Annalisa Nardone
Angelo Virgilio Paradiso
Cosmo Maurizio Ressa
Pasquale Tamborra
Vito Lorusso
Raffaella Massafra
author_sort Maria Colomba Comes
title Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
title_short Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
title_full Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
title_fullStr Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
title_full_unstemmed Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
title_sort early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast dce-mris
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0c54abc80b30475eb5c5e7ab5ee519b9
work_keys_str_mv AT mariacolombacomes earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT annaritafanizzi earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT samanthabove earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT vittoriodidonna earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT sergiodiotaiuti earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT danielelaforgia earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT agneselatorre earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT eugeniomartinelli earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT ariannamencattini earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT annalisanardone earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT angelovirgilioparadiso earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT cosmomaurizioressa earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT pasqualetamborra earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT vitolorusso earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
AT raffaellamassafra earlypredictionofneoadjuvantchemotherapyresponsebyexploitingatransferlearningapproachonbreastdcemris
_version_ 1718384094239260672